WP Advisors LLC Sells 101 Shares of The Procter & Gamble Company (NYSE:PG)

WP Advisors LLC reduced its position in The Procter & Gamble Company (NYSE:PG) by 7.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,323 shares of the company’s stock after selling 101 shares during the quarter. WP Advisors LLC’s holdings in Procter & Gamble were worth $229,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in PG. Itau Unibanco Holding S.A. bought a new stake in shares of Procter & Gamble in the second quarter valued at about $28,000. Fairway Wealth LLC purchased a new position in Procter & Gamble in the second quarter valued at about $29,000. POM Investment Strategies LLC purchased a new position in Procter & Gamble in the second quarter valued at about $34,000. Quest Partners LLC purchased a new position in Procter & Gamble in the second quarter valued at about $36,000. Finally, Fairfield Financial Advisors LTD purchased a new position in Procter & Gamble in the second quarter valued at about $44,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Trading Up 1.5 %

Shares of PG stock opened at $169.54 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The company has a market cap of $399.27 billion, a price-to-earnings ratio of 29.23, a PEG ratio of 3.67 and a beta of 0.42. The stock has a 50 day simple moving average of $170.32 and a 200-day simple moving average of $168.40. The Procter & Gamble Company has a 1-year low of $142.50 and a 1-year high of $177.94.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business’s quarterly revenue was down .6% on a year-over-year basis. During the same period in the prior year, the company posted $1.83 EPS. On average, equities research analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.37%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.

Analyst Upgrades and Downgrades

PG has been the topic of several analyst reports. DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Thursday, August 29th. Piper Sandler started coverage on Procter & Gamble in a research note on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price on the stock. TD Cowen started coverage on Procter & Gamble in a research note on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price target on the stock. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, Morgan Stanley boosted their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $177.00.

Insider Transactions at Procter & Gamble

In related news, CEO Jon R. Moeller sold 37,240 shares of the stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the completion of the transaction, the chief executive officer now directly owns 263,537 shares of the company’s stock, valued at approximately $44,508,763.93. This represents a 12.38 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Susan Street Whaley sold 450 shares of the stock in a transaction on Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total value of $76,149.00. Following the completion of the transaction, the insider now directly owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. This represents a 3.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 313,597 shares of company stock valued at $53,268,499 in the last three months. 0.18% of the stock is currently owned by company insiders.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.